Shicheng Guo

6.7k citations
116 papers · 3.3k indexed · 3 hit papers · h-index 31
Topics
Epigenetics and DNA Methylation (29 papers)RNA modifications and cancer (20 papers)Rheumatoid Arthritis Research and Therapies (15 papers)

In The Last Decade

Shicheng Guo

106 papers receiving 3.2k citations

Hit Papers

Identification of methylation haplotype blocks aids in de...2017202620202023201720212024100200300

Peers

Shicheng Guo
Comparison fields: 5 of 134
  • Molecular Biology 2.0k
  • Cancer Research 989
  • Oncology 476
  • Rheumatology 436
  • Immunology 425
Replace Anthony W. Ashton with:
Anthony W. Ashton United States
Azeddine Atfi France
Akiteru Goto Japan
Hiroaki Taniguchi Japan
Wei Tan China
Ganapati H. Mahabeleshwar United States
Chizu Tanikawa Japan
Jin Hyen Baek United States
Jean‐Pierre David Germany
Hao Zhang China
Shicheng Guo relative to Anthony W. Ashton United States Anthony W. Ashton's profile →
Citations per field
00.5×3.0×
Anthony W. Ashton · 1×
Citations per year

Countries citing papers authored by Shicheng Guo

Since Specialization
Citations

This map shows the geographic impact of Shicheng Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shicheng Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shicheng Guo more than expected).

Fields of papers citing papers by Shicheng Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shicheng Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shicheng Guo. The network helps show where Shicheng Guo may publish in the future.

Co-authorship network of co-authors of Shicheng Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Shicheng Guo. A scholar is included among the top collaborators of Shicheng Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shicheng Guo. Shicheng Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 0
4 5
5 0
6 13
7 16
8 10
9 10
10 0
11 33
12 89
13 11
14 10
15 6
16 55
17 10
18 20
19 23
20 42

About Shicheng Guo

Shicheng Guo is a scholar working on Rheumatology, Cancer Research and Hematology, having authored 116 papers that have together received 3.3k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (29 papers), RNA modifications and cancer (20 papers) and Rheumatoid Arthritis Research and Therapies (15 papers). The work is most often cited by research in Cancer Research (989 citations), Molecular Biology (2.0k citations) and Rheumatology (436 citations). Shicheng Guo has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Jianan Zhao, Dongyi He, Steven J. Schrodi, Jiucun Wang, Jin Li, Ping Jiang, Kang Zhang, Dinh Diep, Kun Zhang and Ho-Lim Fung. Their work appears in journals such as Nature Genetics, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026